CIM
HOLX

Contravisory Investment Management’s Hologic HOLX Stock Holding History

Contravisory Investment Management’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,365
Closed -$511K – 387
2023
Q3 		$511K Buy
7,365
+72
+1% +$5.44K 0.14% 93
2023
Q2 		$591K Buy
7,293
+5,307
+267% +$434K 0.16% 83
2023
Q1 		$160K Buy
1,986
+39
+2% +$3.14K 0.05% 204
2022
Q4 		$146K Buy
+1,947
New +$139K 0.04% 204
2020
Q2 		– Sell
-8,260
Closed -$290K – 282
2020
Q1 		$290K Buy
8,260
+490
+6% +$23.3K 0.13% 83
2019
Q4 		$406K Buy
7,770
+57
+0.7% +$2.84K 0.15% 79
2019
Q3 		$389K Buy
7,713
+2
+0% +$98 0.15% 80
2019
Q2 		$370K Buy
7,711
+10
+0.1% +$462 0.14% 87
2019
Q1 		$373K Buy
+7,701
New +$347K 0.14% 86
2017
Q4 		– Sell
-105,340
Closed -$3.87M – 475
2017
Q3 		$3.87M Buy
+105,340
New +$4.25M 1.38% 42

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Contravisory Investment Management's HOLX Position: Q4 2023 in Review

Contravisory Investment Management sold out of Hologic (HOLX) in Q4 2023, closing a stake of 7,365 shares — an estimated $511K sold.

Contravisory Investment Management first reported a position in HOLX in Q3 2017 and held it in 10 quarters. The position peaked at $3.87M in Q3 2017. 733 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • Contravisory Investment Management reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • Contravisory Investment Management sold 7,365 Hologic shares in Q4 2023, an estimated $511K.
  • Contravisory Investment Management first reported a position in Hologic in Q3 2017 and held it in 10 quarters.
  • Contravisory Investment Management's Hologic position peaked at $3.87M in Q3 2017.
  • 733 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on Contravisory Investment Management's 13F filing for Q4 2023, filed 11 Jan 2024.